Tan S, He H, Ni J, Guo Y, et al. Meta-analysis evaluating the efficacy and safety of various Bruton tyrosine kinase (BTK) inhibitors for central nervous system lymphoma: Novel covalent BTK inhibitors, except for ibrutinib, also demonstrate good efficacy in the treatment of primary ce Cancer 2025;131:e70083.
PMID: 40931981